Who Paid My Doc
CIP326 PCL Feasibility
Research payments
$2,584,915
Through program year 2021, $2,584,915 in research payments was reported against CIP326 PCL Feasibility, across 217 payments.
- Paid by (largest first)
- Medtronic, Inc.; Medtronic MiniMed, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $1,358,322 | 149 |
| 2020 | Research | $988,077 | 47 |
| 2019 | Research | $238,517 | 21 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Christiansen Walnut Creek, CA Named on 20 payments
- Bruce Bode Atlanta, GA Named on 15 payments
- Kevin Codorniz Loma Linda, CA Named on 14 payments
- Ronald Brazg Renton, WA Named on 13 payments
- John Reed Roswell, GA Named on 13 payments
- Anders Carlson Saint Paul, MN Named on 13 payments
- Robert Slover Aurora, CO Named on 11 payments
- Dorothy Shulman Tampa, FL Named on 11 payments
- Yogish Kudva Rochester, MN Named on 11 payments
- David Liljenquist Idaho Falls, ID Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.